Patterson Companies Intrinsic Stock Value – Patterson Companies Posts Impressive Trading Report
November 11, 2023
☀️Trending News
Patterson Companies ($NASDAQ:PDCO) recently released their Trading Report and the news is overwhelmingly positive. Patterson Companies, Inc. is a company that focuses on delivering health and veterinary supplies and services to both medical professionals and animal health professionals. They offer a wide range of items and services from medical and dental equipment to diagnostics, software solutions, and more. This strong performance was attributable to the company’s integrated business model and the continued focus on cost management and operational efficiency throughout the quarter.
In addition, Patterson Companies also announced the acquisition of a medical device company, which will further expand its product offering and customer base. The report also noted that Patterson Companies has benefited greatly from the introduction of several new products and services, as well as the continued growth in demand for products and services related to animal health and medical care. Furthermore, the company is actively engaging in strategic investments in technology and digital capabilities to ensure that they stay ahead of the competition. The company’s integrated business model, cost management focus, and strategic investments have all contributed to the impressive growth. With continued growth in demand for their products and services, along with new acquisitions, Patterson Companies is sure to remain a strong player in the health care industry for years to come.
Share Price
On Tuesday, PATTERSON COMPANIES posted an impressive trading report, opening at $30.6 and closing at $30.3, down by 1.0% from last closing price of $30.6. This demonstrates the company’s stability in the current economic climate; despite a decrease in share prices, the company was still able to post solid numbers. The fact that the stock closed only 1% lower than its opening price indicates that the company is managing its assets well. Live Quote…
About the Company
Income Snapshot
Below shows the total revenue, net income and net margin for Patterson Companies. More…
| Total Revenues | Net Income | Net Margin |
| 6.52k | 214.2 | 2.8% |
Cash Flow Snapshot
Below shows the cash from operations, investing and financing for Patterson Companies. More…
| Operations | Investing | Financing |
| -705.68 | 887.03 | -223.04 |
Balance Sheet Snapshot
Below shows the total assets, liabilities and book value per share for Patterson Companies. More…
| Total Assets | Total Liabilities | Book Value Per Share |
| 2.88k | 1.77k | 11.61 |
Key Ratios Snapshot
Some of the financial key ratios for Patterson Companies are shown below. More…
| 3Y Rev Growth | 3Y Operating Profit Growth | Operating Margin |
| 6.5% | 31.0% | 4.9% |
| FCF Margin | ROE | ROA |
| -11.8% | 17.8% | 6.9% |
Analysis – Patterson Companies Intrinsic Stock Value
At GoodWhale, we have conducted an analysis of PATTERSON COMPANIES‘ fundamentals. Our proprietary Valuation Line indicates that the intrinsic value of the PATTERSON COMPANIES share is around $31.5. At present, the stock is traded at $30.3, which is a fair price and represents an undervalued level of 3.9%. Therefore, investors may consider PATTERSON COMPANIES as a potential investment option. More…
Peers
The company’s competitors include PT Soho Global Health Tbk, BioGaia AB, and ForU Holdings Inc.
– PT Soho Global Health Tbk ($IDX:SOHO)
Soho Global Health Tbk is a leading healthcare company in Indonesia with a market cap of 7.04T as of 2022. The company has a strong focus on providing quality healthcare services to the Indonesian people. It has a wide range of products and services including hospitals, clinics, pharmacies, and medical equipment. The company has a strong focus on research and development to bring new and innovative products to the market. The company has a strong financial position with a return on equity of 15.28%.
– BioGaia AB ($LTS:0GTN)
Biogaia AB is a Swedish biotechnology company that develops, manufactures, and markets probiotic products for human and animal health. The company focuses on the development of lactic acid bacteria for the prevention and treatment of gastrointestinal diseases. Its products include Probio-Kid, a probiotic supplement for children; Probio-Stick, a probiotic supplement for adults; and BioGaia Protectis, a probiotic infant formula. Biogaia AB was founded in 1990 and is headquartered in Stockholm, Sweden.
– ForU Holdings Inc ($OTCPK:FORU)
Founded in 2013, U.S.-based ForU Holdings Inc is a provider of solar panel installation services. As of 2022, the company had a market capitalization of $3.61 million and a return on equity of 65.19%. The company’s solar panel installation services are available in the United States, Canada, and the United Kingdom.
Summary
.
